TrialDrugs in R&D2022

First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants.

Fumihiko Koiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.